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ABSTRACT
MicroRNAs (miRNAs) are involved in various bio-
logical processes by suppressing gene expression.
A recent work has indicated that host miRNAs
are also capable of regulating viral gene expression
by targeting the virus genomes. To investigate
regulatory relationships between host miRNAs
and related viruses, we present a novel database,
namely ViTa, to curate the known virus miRNA
genes and the known/putative target sites of human,
mice, rat and chicken miRNAs. Known miRNAs
are obtained from miRBase. Virus data are collected
and referred from ICTVdB, VBRC and VirGen.
Experimentally validated miRNA targets on viruses
were derived from literatures. Then, miRanda and
TargetScan are utilized to predict miRNA targets
within virus genomes. ViTa also provides the virus
annotations, virus-infected tissues and tissue spe-
cificity of host miRNAs. This work also facilitates
the comparisons between subtypes of viruses, such
as influenza viruses, human liver viruses and the
conserved regions between viruses. Both textual
and graphical web interfaces are provided to facili-
tate the data retrieves in the ViTa database. The
database is now freely available at http://vita.mbc.
nctu.edu.tw/.
INTRODUCTION
MicroRNAs (miRNAs) are small RNA molecules,  22 nt,
that can regulate gene expression by interfering in the
post-transcriptional level, which results in the degradation
of mRNAs and repression of translation by the pairing of
bases to the 30-untranslated regions (30-UTRs) of the
mRNAs. The miRNAs are derived from hairpin-like precur-
sor transcripts (pre-miRNAs) that are  70–120 nt long
sequences. These structures are believed to be recognized
and taken out of nucleus by exportin 5. Pre-miRNA is then
cleaved by Dicer (a ribonuclease III enzyme) to excise the
mature miRNAs in the form of siRNA-like duplexes
and asymmetrical assembling of the mature miRNA strands,
which may be decided upon relative thermodynamic charac-
teristics of the two 50 termini of strands, combining with the
Argonaute proteins into effector complexes (1).
Recent studies show that some miRNAs can target the viral
RNA transcripts after viruses enter into cells, and those host
miRNAs appear to play varied roles in affecting viruses. For
example, human liver-speciﬁc miR-122a induces hepatitis
C virus (HCV) replication by targeting to the 50-non-coding
region (NCR) (2), and HIV is suppressed by targeting several
genes by human miRNAs (3). These indicate that human
miRNAs can regulate the life cycle of viruses in hosts.
Figure 1 depicts the concept of possible regulatory relation-
ship between host miRNAs and viruses. The interaction
between viruses and host miRNAs is worthy of further
research (more description). For example, miRNAs may
contribute to cancer, miRNA-mediated tumorigenesis results
from either down- or up-regulating virus activity.
Compared with related works in animals and plants,
research investigations on miRNAs and viruses are in its ini-
tial stages. HCV is the major causative viral agent of cirrhosis
and hepatocarcinoma. Analysis of the genetic interaction
between human miR-122 and the 50-NCR of the HCV
genome via the mutation of the predicted miRNA target
site and ectopic expression of miR-122a molecules contain-
ing compensatory mutations indicated that human miR-122a
is likely to facilitate the replication of the viral RNA, and
may present a target for antiviral intervention (2).
Another HIV is also predicted as miRNA targets (3).
Human miRNAs that are expressed in T-cells, the natural
site of infection by HIV-1 infection, may target HIV-1 genes
and related clade sequences at highly conserved target sites.
These studies imply that human miRNAs potentially affect
the expression of HIV-1 genes and could be utilized in devel-
oping therapies to inhibit HIV-1 in future. Lecellier et al.
(4) demonstrated that cellular miRNAs effectively restrict
the accumulation of retrovirus primate foamy virus type
1 (PFV-1) in human cells. Conversely, PFV-1 also encoded
a protein named Tas, which suppresses miRNA-directed
functions in mammalian cells and displays cross-kingdom
anti-silencing activities. Therefore, through fortuitous recog-
nition of foreign nucleic acids, cellular miRNAs have direct
antiviral effects in addition to their regulatory functions (4).
The various relationships between viruses and miRNAs are
worthy of further investigation.
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roles in various biological processes. The miRBase (5) sup-
ports the information for published miRNA genes and
miRNA targets. miRNAMap (6) is a comprehensive informa-
tion repository for the miRNAs and their targets in human,
mouse, rat and dog genomes. Furthermore, several miRNA
target prediction programs were developed previously. Tar-
getScan (7), miRanda (8) and RNAhybrid (9) are commonly
used to determine the energetically most favorable hybridi-
zation sites of miRNA target prediction. Lu et al. (10) devel-
oped an miRNA microarray for measuring the expression
proﬁles of all known miRNAs in various normal tissues
and tumors, which provides valuable information for accu-
rately predicting miRNA targets on viruses.
To facilitate the research on the roles of host (human, mice,
rat and chicken) miRNAs in viral infection,this work develops
a database, namely ViTa, which comprises known miRNAs
on host, known and putative host miRNA targets on viruses,
and relationshipamong viruses,miRNAs and diseases.
After collecting data, sequences are preprocessed upon
life cycle of viruses. Then, the miRNA targets within virus
genomes are predicted by miRanda and TargetScan. Further-
more, similarity among sequences is compared with subtypes
in every species to ﬁnd the conserved regions. Finally, the
relationships between miRNAs and targeted viruses are iden-
tiﬁed and integrated by ViTa database, which also contains
annotation of viruses, virus-infected tissues and the tissue
speciﬁcity of miRNAs, conserved regions on virus and statis-
tical results for user. Thus, the ViTa database not only
provides miRNAs and miRNA targets, but also expression
proﬁles of known host miRNAs, virus annotation and cross-
links to other biological databases, and the comparison bet-
ween viruses, such as inﬂuenza viruses, hepatitis B virus,
HCV and combination of miRNAs.
This work establishes the computational relationship
between the host miRNA genes and viruses. Furthermore,
this work provides effective annotations, including those for
human miRNA expression and virus-infected tissues and
annotations of viruses and comparisons between viruses.
Additionally, various functions and a graphical web interface
are presented that help users in investigating the miRNA roles
in viruses.
DATA GENERATION
Figure 2 presents the data generation ﬂow of the ViTa data-
base. The ﬂowchart comprises the following three main steps:
(i) collect data from databases and the literature; (ii) mine
information from collective data and handle sequences; and
(iii) predict host miRNA targets on viruses. Each step is
described in detail below.
Data collection
Known human, mouse, rat and chicken miRNAs are obtained
from miRBase (Release 8.2) (11) and known virus miRNA
targets are collected from the literature.
Collecting virus data are difﬁcult as NCBI releases virus
genomes only for download (except inﬂuenza viruses), and
no classiﬁable, identical virus data packaged exists that
can be directly obtained via the FTP site. Additional data
were obtained from other databases that are linked to
NCBI. Most data are from databases—ICTVdB, VBRC and
VirGen—and surﬁng websites. The ViTa database contains
26870 virus genomes for 2108 species, including genomes
and transcripts. For human-related viruses, there are 15357
records for 446 species.
The ViTa database currently contains 23 virus families that
are classiﬁed into six genome types—dsDNA viruses, ssDNA
viruses, dsRNA viruses, (+) ssRNA viruses, ( ) ssRNA
viruses and retro-transcribing virus. The virus genomes
were obtained from NCBI, ICTVdB, VBRC and VirGen.
Experimentally validated miRNA targets on viruses and
the information of virus-infected tissues were extracted by
surveying literature.
Expression proﬁles of miRNAs were obtained from the
dataset constructed by Lu et al. (10).
Afterﬁnishingdatacollection,thesecondstepinvolvesmin-
ing information from varied datasets. Because virus data are
non-identical, i.e. virus name, strain, serotype, hosts and
virus-infected tissue are lacking. To resolve this problem,
other virus databases and related literature are accessed. First,
the virus names are altered to unite in all datasets. The ViTa
Figure 2. The ViTa flowchart.
Figure 1. MiRNAs interact with target mRNA in viruses and host cells.
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cal classiﬁcation (order, family, subfamily, genus and species)
to facilitate user research. To identify hosts and virus-infected
tissues, various sources, such as databases and literatures are
accessed. Viral RNA genomes and viral mRNAs are prepared
topredictmiRNAtargets,thoseRNAsequenceswereclassiﬁed
as mRNA, positive-strand RNA and negative-strand RNA
according to the viral genome types.
Predicting host miRNA targets on viruses
In this work, miRanda (8) and TargetScan (7) were applied to
identify the host miRNA target sites in viruses. The minimum
free energy (MFE) of the miRNA–target duplex was deter-
mined in predicting the miRNA target sites. Low-MFE values
of the miRNAs and the target sites reveal the energetically
more probable hybridizations between the miRNAs and the
target genes. However, these parameters are likely to grossly
overpredict the number of miRNA targets per gene. Alterna-
tively, the proposed database allows users to consider a set of
parameters that is more stringent and gives less likely false
positives. Thus, the predictive parameters, including the
cutoff of miRanda MFE and the cutoff of miRanda score,
can be adjusted for the miRNA target prediction.
The regulatory relationships between the host miRNAs and
the related viruses are determined with reference to the anno-
tations and the organization of viruses. This work supports
the expression proﬁles of known host miRNAs, the cross-
species virus comparisons, annotations and various links to
biological databases. The conserved regions in each species
in the database were obtained using BLAST (12). Supple-
mentary Table S1 gives the list of integrated databases. The
expression proﬁles of the miRNAs, which were obtained
from the dataset constructed by Lu et al. (10), are useful in
elucidating the regulatory roles of miRNAs. Moreover, the
tissue speciﬁcity of known miRNAs is used to examine the
relationship between host miRNAs and viruses, both of
which exist in the same tissue.
DATABASE STATISTICS
Table 1 gives the statistics of virus genomes collected in the
proposed database. The MFE of the miRNA/target duplex
was determined by miRanda and TargetScan to predict
miRNA target sites. Low-MFE values of the miRNA/target
duplex indicate likely hybridizations between the miRNAs
and the targeted viruses. Table 2 presents statistics for the
known human miRNA targets on virus, which can also be
predicted by both miRanda and TargetScan except that
hsa-miR-32/PFV-1 cannot be predicted by TargetScan. The
known miRNA targets on HCV can be identiﬁed when
the miRanda MFE threshold and miRanda score threshold
are set at  10 kcal/mol and 120, respectively. However,
these parameters are likely to grossly overpredict the number
of miRNA targets on viruses.
Alternatively, the proposed database allows users to utilize
a set of predictive parameters that is more stringent and
obtains fewer false positives than thresholds. All predictive
miRNA targets, of which the MFE is < 10 kcal/mol and
the score is >120, are determined and stored in ViTa data-
base. Table 3 gives the statistics of miRNA targets on viruses
with different predictive parameters. For instance, if the MFE
cutoff is set at  20 kcal/mol and score cutoff is set at 120, the
average number of targeted viruses for each miRNA is
83.65 and the average number of distinct miRNAs targeting
to each virus is 64.50. Similarly, when the MFE cutoff is
set to  10 kcal/mol and score cutoff is set at 160, the average
number of the targeted viruses for each miRNA is 50.64
and the average number of distinct miRNAs targeting each
virus is 33.75. Furthermore, Supplementary Table S4 presents
the statistics of miRNA targets predicted using TargetScan.
Supplementary Table S5 presents the statistics for miRNA
targets on several liver-speciﬁc viruses. Supplementary -
Table S6 presents the statistics for human miRNA targets
on inﬂuenza viruses.
INTERFACE
The proposed web interface provides variety of data for both
browsing functions and search functions. The database pro-
vides two ways for browsing the miRNA targets on viruses:
(i) browse by genome types and (ii) browse by taxonomy.
It allows users to search the database by keywords, accession
numbers, disease names and virus-infected tissue preference
(Supplementary Figure S2). Supplementary Figure S1
demonstrates the conserved regions between virus species,
Table 1. Statistics of virus genome collected in ViTa
Host Total
Human Mouse Rat Avian Other
Liver-related viruses 285
Influenza viruses 12137 414 37 2529 10333 28670
Other disease virus 3135
15357
Table 2. Known host miRNAs targets on viruses predicted by miRanda and TargetScan
Human miRNAs Target virus References By miRanda By TargetScan
Score MFE (kcal/mol) MFE (kcal/mol)
hsa-miR-122a HCV 1a strain H77c (AF011751) (2) 146.00  14.30  20.10
has-miR-122a HCV 1b strain HCV-N (AF139594) (2) 148.00  15.70  24.10
 20.10
has-miR-29a HIV-1 isolate BRU (K02013) (3) 175.00  22.10  29.20
has-miR-29b HIV-1 isolate BRU (K02013) (3) 179.00  23.00  31.30
has-miR-149 HIV-1 isolate BRU (K02013) (3) 194.00  26.60  32.10
has-miR-324-5p HIV-1 isolate BRU (K02013) (3) 191.00  24.50  32.70
has-miR-378 HIV-1 isolate BRU (K02013) (3) 177.00  25.30  31.10
has-miR-378 HIV-1 isolate ELI (K03454) (3) 177.00  25.30  31.10
has-miR-32 PFV-1 (4) 120.00  9.91 —
Nucleic Acids Research, 2007, Vol. 35, Database issue D383detailed information about targeted viruses and the tissue
speciﬁcity of the miRNA targets.
Figure 3 presents a visualization tool that is used to present
the miRNA targeting the viruses. All miRNAs target sites
are also provided in the text format, including the genomic
locations of target sites, the MFE of miRNA/target duplex,
target site sequences and the alignment of hybridization
structures. The detailed documentation for the usage of
ViTa is provided on the web interface.
CONCLUSIONS
This work presents a novel database for host miRNA targets
on virus genomes and virus transcripts. The database com-
prises known host miRNAs, known viral miRNAs, known
host miRNA targets on viruses and putative host miRNA
targets on viruses. We believe that the proposed resource can
provide sufﬁcient and effective information for the investi-
gation about the interaction between host miRNAs and viral
genes. The information about the tissue preferences of viruses
is effective to combine the tissue speciﬁcity of host miRNAs
for further analysis of miRNA targets on viruses in ViTa. For
instance, HCV prefers to infect the liver and miR-122a is a
liver-speciﬁc miRNA. Thus, the miR-122a targets discovered
in HCV are signiﬁcantly interesting.
The prospective works of the database are as follows:
(i) more expression proﬁles for host miRNA genes will be
supported; (ii) combinatorial miRNA regulation to viral
gene expression can be identiﬁed by computational analysis
and miRNA-related gene expression proﬁles; and (iii) the
association between virus and disease will be explored by
clinical data collection.
AVAILABILITY
The ViTa database is continuously maintained and updated.
The database is now freely available at http://vita.mbc.nctu.
edu.tw.














< 10 229.13 260.93 33754.86
< 15 188.96 188.47 11693.65
< 20 83.65 64.50 1755.98
< 25 19.13 9.66 182.86
Score > 140
< 10 170.40 156.92 6174.33
< 15 132.66 113.22 3524.48
< 20 56.19 38.77 819.14
< 25 14.06 6.63 117.03
Score > 160
< 10 50.64 33.75 620.39
< 15 45.21 29.52 537.10
< 20 22.37 12.88 213.28
< 25 8.41 3.29 61.24
Score > 180
< 10 5.81 2.03 44.48
< 15 5.81 2.03 44.48
< 20 5.53 1.93 37.68
< 25 3.91 1.49 28.58
Score > 200
< 10 3 1 6.33
< 15 3 1 6.33
< 20 3 1 6.33
< 25 3 1 6.33
Figure 3. Interface of putative targeted viruses in ViTa.
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